On 28-20 September one of the most significant events of the Saint
Petersburg business life - IV Saint Petersburg international innovative
forum - took place.
The event organized by the government of St. Petersburg has focused on
the stimulation and development of the innovative activity in Russia,
as well as development of key decisions on the implementation of the
innovative economic development. Among the forum participants - there
were more than 10 thousand people – were representatives of the leading
Russian and foreign companies, officials, experts, whose professional
activity is related to innovative development. The event program has
implied holding of congress and business parts as well as extensive
exposition of innovative projects.
One the main aims of the forum in Saint Petersburg is making of
efficiency dialogue and cooperation between all participants of the
innovative process including the investors and the city administration.
In addition, the event represents the innovative development of the
leading Russian and foreign companies.
On September 29 within the forum a meeting of the Coordination Council
for development of the pharmaceutical cluster of St. Petersburg with
the participation of the city government. Representatives of the
companies participating in the pharmaceutical cluster, city
administration as well as R&D institutes have gathered to discuss
topical issues of the cluster’s development in the region. Heads of the
leading pharmaceutical companies have told about their current projects.
Peter Rodionov, CEO of GEROPHARM, has made a report and informed about
current status and future plans of the construction of the production
complex in the industrial zone “Pushkinskaya” and R&D-center in SEZ
Last week a decree by the St. Petersburg government about change of
the terms of the investment agreement with the GEROPHARM and extension
of the company’s territory in the industrial zone “Pushkinskaya” up to 7
hectares were accepted. It will contribute to increase the territory of
the unique high-tech production complex that is currently being built
by company for the production of the pharmaceutical drugs. Expansion of
the production areas required subject to plans to expand the range of
drugs and new directions of the innovative development which were chosen
by the company. The first stage of the construction of the industrial
complex is planned to finish by company in 2014.
Construction of R & D-center in the SEZ "Neudorf" is in the final
stage. The main research directions of the new laboratory will be
innovative peptide and human recombinant drugs of the new generation,
state-of-the-art diagnostic systems as well as improved generic drugs,
which will be produced in the new facilities. Pharmaceutical development
(complex of procedures for the development, analysis and adoption of
the new drugs) which will be implemented in company’s R&D-center in
SEZ “Neudorf” will speed up the process of adoption of the laboratory
products in industrial production, as well as to minimize technical
problems of that transactional stage.
The company "GEROPHARM" also took part in the exposition of the event and presented their projects to visitors on the stand of the St. Petersburg pharmaceutical cluster.